To observe the Safety and tolerability of Capecitabine Tablet 500 mg and XELODAÂ tablets in Subjects with Metastatic Breast Cancer, Dukes C Colon Cancer or metastatic Colorectal Cancer Under Fed Condition.

Intervention1: Capecitabine: 500 mg (Single dose)
Control Intervention1: XELODAÂ (Capecitabine): 500 mg (Single Dose)
Primary outcome(s): Cmax: Maximum measured plasma concentration over the time span specified.
AUCt: The area under the plasma concentration versus time curve will be calculated using the linear trapezoidal rule from the zero time point to the last quantifiable concentration.
Timepoint: Will be Calculated after end of treatment period.